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ABSTRACT  
It is two hundred years since James Parkinson published An Essay on 
the Shaking Palsy. While his monograph continues to be acclaimed 
for its precedence and clarity of description, what is often 
overlooked is the originality of Parkinson’s ideas. We show that he 
appreciated the weakness of the systematic eighteenth century 
nosologies, which presupposed that medical species, the building 
blocks of these Linnaean taxonomic schemes, were as distinct as 
plant and animal species; and that Parkinson made a conceptual leap 
about combinations of clinical phenomena in recurring patterns, now 
recognized to be one of the germs of neurological thinking about 
syndromes.  The Essay’s written style underpins another aspect of 
significance to contemporary neurological practice—an inherent 
intellectual humility. In this commemorative year we locate the 
continuing importance of the related notions of syndrome and 
disease in successive frameworks of knowledge about the Shaking 
Palsy. Syndrome and disease are interpreted as dual character 
concepts, one clinically-based and the other restricted to 
pathophysiological causation. They both remain fundamental to 
understanding Parkinson’s syndrome-disease today. 
              
171 words. 
 
  
Introduction 
James Parkinson (1755 – 1824), who published An Essay on the 
Shaking Palsy two hundred years ago, owes his lasting reputation to 
the disease which it described.[1] As a result of the universality of 
the name and the frequency of the disorder, Parkinson has been 
hailed as the world’s best-known neurologist,[2] though he 
designated himself, in both his publications and his will, as a 
‘surgeon-apothecary’ (his main medical affiliations were to the 
Company of Surgeons, later the Royal College of Surgeons, and from 
1814 to the Association of Apothecaries and Apothecary Surgeons of 
England and Wales). Despite his eponymous fame, the originality of 
his ideas about how clinical observations could be segregated into 
diagnostic entities is often overlooked.  
Parkinson went beyond previous taxonomic approaches to tremor 
that relied on classification by sub-division, and thought instead in 
terms of combinations of clinical phenomena recurring in 
recognisable spatio-temporal patterns. This is the conceptual leap of 
his monograph, and it represents one of the germs of neurological 
thinking about syndromes. Its innovatory nature explains why the 
shaking palsy had not hitherto ‘obtained a place in the classification 
of nosologists’ despite its distinctive appearance.[1] Although he did 
not employ the word syndrome, his Essay illustrated how the linking 
together of a set of disparate clinical features can serve as a valuable 
template of deferred understanding. As it happened, more than a 
century elapsed before a lesion in the pars compacta of the 
substantia nigra was accepted as the single most consistent site of 
brain damage associated with the cardinal clinical features described 
in the Introduction to his monograph. 
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Terminology inevitably reflects the evolution of our knowledge in 
medicine.  This article argues for the continuing intellectual 
importance of James Parkinson’s contribution to contemporary 
neurological practice by placing the related notions of syndrome and 
disease in the successive frameworks of knowledge which developed 
out of his Essay. 
Syndrome and disease as constructs 
The Greek source word σύνδρομον has the sense of a concurrence of 
things. One popular modern definition of a syndrome is a collective 
manifestation or pattern of clinical phenomena that is repeatedly 
observed but not completely understood or explained.  It is a 
configuration of components or parts which is assumed to reflect a 
more fundamental process, such as a type or class of pathological 
mechanism. 
The literary philosopher Kenneth Burke (1897-1993) in his A 
Grammar of Motives wrote that while ‘much service has been got by 
following Occam’s law to the effect that Entities should not be 
multiplied beyond necessity, much of disservice has arisen through 
ignoring a contrary precept, which states: Entities should not be 
reduced beyond necessity.’[3] Syndromes insist that some discernibly 
discrete elements ‘belong together’. They invoke a combinatory 
process that reduces the ‘blooming, buzzing confusion’ of clinical 
phenomena[4] to a smaller number of compound forms (‘atoms to 
molecules’, ‘letters to words’).  
Disease entities are held to have more credence and conceptual 
solidity than syndromes because awareness of their pathological, 
biochemical or genetic aetiology is implied.  In clinical medicine, 
however, distinction between denotative and connotative 
descriptors is blurred, disease and syndrome frequently being used 
synonymously. A syndrome can refer to a constellation of clinical 
features that has more than one defined cause, and the term is now 
also used to describe a single complex symptom such as chronic 
fatigue. 
James Parkinson’s Essay: a composition of its time 
James Parkinson’s Essay was a work in an older tradition of enquiry 
in which observation and classification were the foundation for new 
medical knowledge. Like many doctors of his generation, Parkinson’s 
scientific interests were not restricted to medicine. He wrote 
treatises and papers on geology, fossils and chemistry, and was well 
acquainted with the principles of study of chemical and earth 
sciences. The development of palaeontology occurred in his lifetime, 
as did the botanical discoveries of the voyages of James Cook (1728-
1779) and the French navigator-scientists Lapérouse, 
d'Entrecasteaux (1737-93) and Nicolas Baudin (1754-1803), the 
resultant knowledge being given classificatory structure by the 
Linnaean taxonomy of the living world; and William 'Strata' Smith 
conferred order on the subterranean world when he published his 
first geological map of Britain in 1815. 
 
The idea of identifying defining characteristics of a specific biological 
entity would have been familiar to Parkinson from his work on 
fossilised marine animals. His Essay argued that certain disparate 
clinical phenomena should be joined together: tremor ‘of parts not in 
action’; what we now call a propulsive shuffling gait; and a weakness 
or failure of ‘dictates of the will’ to achieve movement. He also 
realised that the shaking palsy had a visible presence on the busy 
streets of London (see Figures 1 and 2). 
 Figures 1 and 2 about here  
 Though the medical knowledge of the ancient world had lost much 
of its relevance, Parkinson respectfully mentioned Galen’s ideas on 
tremor. Since the mid-1700s, classification of diseases had tended to 
follow the Linnaean binomial system of genus and species. 
Parkinson’s Essay refers to Carl Linnaeus’s (1707 – 1778) generic 
term for involuntary movement, which he thought was separate 
from the shaking palsy (Linnaeus’s system of disease classification 
was much less successful than his Systema Naturae of 1735 for 
botany and zoology). François Boissier de Sauvages de Lacroix (1706 - 
1767), who was a botanist before becoming a physician, and was a 
friend of Linnaeus, was credited by Parkinson for having identified 
some elements of the shaking palsy in his Methodical Nosology 
(1763).[5] Sauvages’s separate species of tremor coactus and 
sclerotyrbe festinantem seemed to correspond to rest tremor and a 
hurrying or propulsive gait, but he had made no attempt to see them 
as part and parcel of a single entity. 
The systematic eighteenth century nosologies which the Essay 
reviews—those of Linnaeus, Vogel, Sauvages and Cullen—were 
vertical arrangements of categories such as Class, Order, Genus and 
Species which presupposed that medical species, the building blocks 
of these taxonomic rankings, were as distinct as plant and animal 
species appeared to be. Parkinson realised that some medical 
phenomena did not reflect a unitary significance and that cross-
genera grouping was needed to account for his observations.  
The term paralysis agitans, which Parkinson uses sparsely in his 
Essay, maintained continuity with the Latin binomials of the Linnaean 
nosologists, but his preference for the plain English of ‘the Shaking 
Palsy’ represents a further point of departure. His ‘assemblage of 
symptoms’ took on the status of a syndrome which in this instance 
combined different genera and species, and thereby transcended the 
prevailing hierarchical system used to categorize clinical signs and 
symptoms.  
 Parkinson identified constipation, drooling of saliva, sleep 
disturbance and, possibly, psychological changes as clinical 
phenomena seen in sufferers of the shaking palsy. It was twentieth 
century neurologists who played down these symptoms, particularly 
in textbook descriptions.[6,7] Parkinson also made pertinent 
observations on the course of the condition. Its insidious onset, he 
thought, could have a prodromal phase of regional rheumatism.[1] 
He had an approximate idea of the course of the illness and its 
spread to different body parts and functions, and he also recognised 
some of the features of its advanced stage.   Although he noted that 
delirium could occur terminally, he emphasised ‘the absence of any 
injury to the senses and to the intellect, [and] that the morbid state 
does not extend to the encephalon’.[1] This contention may not have 
been inaccurate bearing in mind the duration of disease and the 
average age of the patients he observed.[8] 
 
The evolution of James Parkinson’s syndrome-disease 
James Parkinson published information on six individuals who 
suffered from the shaking palsy, one of whom he had only seen at a 
distance.  Parkinson thought the patients he described were affected 
by a weakness, which he distinguished from other forms of palsy. 
‘The dictates of the will,’ he wrote, ‘are even, in the last stages of the 
disease, conveyed to the muscles… but their actions are 
perverted’.[1] He saw weakness as an early and defining sign of the 
condition.  Charcot (1825-1893) said that weakness in the shaking 
palsy was largely illusory since patients could produce good muscular 
power when encouraged to do so, which he verified with a 
dynamometer.[9]  In his Tuesday lectures Charcot emphasised 
slowness of movement and muscle rigidity as defining 
characteristics, which he distinguished from the spasticity of a spinal 
cord lesion. Trousseau was even more incisive about the particularity 
of the movement disorder, noting that one of his patients became 
progressively slower when asked to repeatedly open and close his 
hand, thus anticipating the modern concept of bradykinesia 
(progressive reduction in speed and amplitude of sequential 
voluntary movement).[10] 
 
Parkinson identified some of the changes in posture associated with 
the condition: ‘After a few more months the patient is found to be 
less strict than usual in preserving an upright posture: this being 
most observable whilst walking’.[1] Facial freezing, a clinical sign that 
potentially could have been identified by Parkinson’s field work, was 
described by Charcot. Trousseau and some of the French alienists 
like Ball and Naville appreciated that eventual intellectual weakening 
could occur in older patients.[11,12] 
 
Charcot coined the term maladie de Parkinson. He paid tribute to 
Parkinson’s ‘vivid and descriptive definition’[13] but he was also 
seeking a new terminology that reflected his realisation that tremor 
was not an obligatory component of the syndrome. William Gowers 
(1845 - 1915) disliked eponyms and preferred ‘the shaking palsy’ 
although in his Manual of 1878 he reverted to the then more widely 
accepted term paralysis agitans.[14] 
In 1919 Konstantin Tretiakoff (1892 – 1958) identified a loss of 
pigmented substantia nigra neurons[15] in association with the same 
intracellular inclusions that Lewy had reported seven years 
before.[16] Neither of these findings was universally agreed to be 
pathognomonic for Parkinson’s disease (PD) until the influential 
confirmatory papers published by Hassler and then by Greenfield 
and Bosanquet.[17,18] The acknowledgement of secondary causes of 
the condition such as post-encephalitic parkinsonism, vascular 
parkinsonism and parkinsonism in manganese miners brought into 
sharp focus the distinctions between syndrome and disease. While 
clinicians were generally able to distinguish these disorders from one 
another, some authors questioned whether the maladie de 
Parkinson was really a disease at all.[19,20] 
 
Progressive supranuclear palsy and multiple system atrophy, 
delineated in the 1960s as a result of clinico-pathological studies, are 
now established as distinct diseases that frequently present with 
bradykinesia, rigidity and postural deformity. Brain bank research 
showed that in routine clinical practice more than 15% of patients 
diagnosed with PD and who retained that diagnosis until the end of 
their lives, have an alternative pathological explanation, mostly 
either progressive supranuclear palsy or multiple system 
atrophy.[21] The development of clinical diagnostic criteria capable 
of a higher degree of correlation with typical pathological findings 
derives from a determination to preserve PD as a distinct clinical 
identity within a growing number of neuropathologically distinct 
parkinsonian syndromes. The primacy of the physical sign of 
bradykinesia in the clinical diagnosis of PD stems from this phase of 
clinico-pathological research. The disorder now also encompasses 
biochemical parkinsonism (nigrostriatal dopamine deficiency from 
enzyme defects, with levodopa responsiveness) and monogenetic 
parkinsonism with and without typical Lewy pathology. In contrast, 
the eponym Alzheimer’s disease stemmed from a single detailed 
clinico-pathological case report and, until the nineteen sixties, 
described a rare degenerative amnesia.[22] The realisation that the 
pathological lesion was identical to the commonest cause of 
dementia led to a broadening of its use. 
 
The Braak model of topographic pathological progression hinges on 
the acceptance of Lewy bodies as a harbinger of selective neuronal 
loss,[23] and on this basis proposes that the pathological process of 
Parkinson’s disease involves the olfactory, autonomic and enteric 
nervous systems. This notion has further destabilised the word 
‘disease’ as designating a specific relationship between clinical 
features and pathophysiology in PD. If regional neuronal 
degeneration is confirmed to begin outside the substantia nigra and 
to spread eventually far beyond it, a new concept for James 
Parkinson’s syndrome-disease may be needed. 
From a clinical perspective, this approach runs into the difficulty that 
hyposmia, constipation and sleep disorders do not reliably predict 
the development of tremor, bradykinesia and rigidity. Furthermore, 
the majority of people with these non-motor complaints have no 
nigral degeneration or Lewy body pathology. 
 
Syndrome and disease as dual characteristics 
There is a dynamic tension between syndrome and disease, which 
can inspire new thinking about clinical entities. Syndromes embody 
the clinical approaches of phenomenology, fieldwork, semiotics and 
pattern recognition, and preserve an impression of how a disorder is 
experienced by a patient and encountered in the clinic. Diseases, on 
the other hand, conform more closely to knowledge about aetiology 
and mechanisms which carries implications for the development of 
possible treatments.  
Evidence-based approaches or consensus diagnostic criteria drafted 
by expert committees are now the favoured approach to maintain 
nosological rigour and consistency of disease diagnosis, but this 
process has the drawback of relying heavily on review articles and 
meta-analyses rather than on individual clinicians’ accumulated 
diagnostic acumen or a patient’s subjective experience. In a sense 
they have replaced the older, respected text book descriptions of 
disease states. 
There are many situations in which something may be characterised 
in two different ways when deciding whether it belongs to a 
particular grouping.[24] One person might have superior technical 
ability to apply pigments to canvas but not progress beyond a limited 
repertoire of images. Another, without particular training or skill in 
painting, may have a talent for visual creativity and a commitment to 
express it. Both could be called artists, each embodying a certain 
sense of the word. Dual characterisations usually operate at two 
contrasting levels—concrete and abstract, superficial and profound, 
or sensual and contemplative. They reveal different judgement 
frames about what defines membership of a category. Although dual 
character analyses may generate contradictions, the end result can 
be one of greater understanding. This way of thinking illuminates 
how syndromes and diseases mesh together within the structure of 
medical knowledge. In approaching the diagnosis of PD, disease 
character should be formulated according to the probability that a 
patient has the typical pathology of severe but not complete loss of 
pigmented neurons in the substantia nigra in association with brain 
stem Lewy bodies. Its syndromic character pertains to the clinical 
domain, being composed of specific motor deficits that would have 
been recognisable to Charcot and Gowers. 
Two new sets of diagnostic criteria for use in PD research, published 
in the same 2015 issue of Movement Disorders, can be looked at in 
terms of this dual syndrome-disease relationship. In the MDS Clinical 
Diagnostic Criteria, motor deficits of bradykinesia, rigidity and tremor 
remain indispensable for the diagnosis of PD, anchoring the scheme 
within a syndromic construct.[25] Other criteria have then been 
overlaid, including responses to pharmacological therapy, clinical 
features more suggestive of other disorders (red flags) and ancillary 
investigations such as neuroimaging; these support a probabilistic 
estimate of typical underlying pathology, and hence disease 
character. Inter-penetration of syndrome and disease characters is 
one source of strength in this new working classification. To prove 
their usefulness in clinical practice and research the criteria now 
need to be validated against expert clinical opinion and existing 
scales.[26] 
                 The creation of the MDS Research Criteria for Prodromal PD 
presents many more challenges.[27] Such an alignment of the dual 
characteristics is denied by the task itself, since it is an attempt to 
engage with a pre-diagnostic phase of the disorder.  A proxy 
syndrome made up of clinical features that might anticipate the fully 
fledged motor syndrome has been drawn up. A disease construct, 
created by Bayesian statistics using prior demographic probabilities 
and likelihood ratios drawn from earlier clinical research, is used to 
try to predict Lewy pathology in the absence of cardinal motor signs. 
It seems clear that a demarcation of PD that encompasses a 
prodromal phase in its syndromic character needs to establish a 
strong correlation with pathologically-based disease character to 
satisfactorily redefine the disorder. 
 
Pride and humility 
An Essay on the Shaking Palsy, with its organised approach and 
astute analysis, is often admired as an early contribution to the 
project of scientific modernity in medicine. Some self-effacing and 
deferential comments that begin and end the Essay are attributable 
perhaps to the courteous turn of phrase of an educated Englishman 
of the Georgian era. But one reason that An Essay on the Shaking 
Palsy strikes a different tone from much modern scientific writing is 
its inherent humility. James Parkinson never wrote in a manner of 
superiority or self-worth, or to emphasise the importance of his 
opinions. The origins of Parkinson’s humility are not easily 
appreciated from the Essay itself, but probably belong to the 
philosophical and medical climate of his era. 
At the end of the eighteenth century, religious belief had to contend 
with several sources of doubt. Rationalist and humanist writers had 
undermined the position of theological learning, while political 
developments like the French Revolution were violently antagonistic 
to the authority of Church. In the long run though, scientific 
advances in natural sciences —especially geology and 
palaeontology—had the most corrosive effects on religious faith. The 
stratification of rock formations seen in coal mines and canal 
excavations and the fossilised remains of strange plants and animals 
found in various geological layers appeared to imply many different 
eras in the history of the earth each of which must have lasted for a 
very long time, which was inconsistent with the straightforward 
interpretation of the biblical account of Creation. 
Some writers at the turn of the nineteenth century thought that 
religion and the new scientific knowledge could yet be reconciled. 
The clergyman William Paley’s influential Natural Theology; or, 
Evidences of the Existence and Attributes of the Deity (1802)[28] had 
updated a traditional Christian idea about nature—that in all its 
recently discovered complexity, it revealed the scheme of its Creator 
and continued to complement the divine revelations contained in 
the scriptures. Paley (1743-1805) began with the argument that as a 
watch implies the existence of a watchmaker, so the natural world 
implies the existence of God. James Parkinson shared these beliefs in 
natural theology, and his Organic Remains of a Former World, 
published nine years after Paley’s volume, attempts to follow the Old 
Testament prehistoric chronology. The subtitle of Parkinson’s book 
refers to the fossilised plants and animals of the antediluvian world; 
in the volume he explained how the stratification of rocks and fossils 
and the deposition of coal could have been formed by the Deluge. 
New discoveries about Nature, he wrote, ‘cannot fail to excite a 
reverential awe, and dispose to the adoration of the Great 
Supreme’[29]  (see Figure 3) Natural theological ideas extended to 
medical knowledge, Paley having also written about diseases and 
their different phenomenological and temporal patterns 
representing God’s grand plan for human experience.[28] 
Even though Parkinson’s Organic Remains of a Former World treats 
fossils as natural formations which are to be investigated empirically 
through experimental investigation and chemical analysis, and 
displays a powerful drive to classify based on form and pattern, it 
retains a Mosaic schema in which each day of creation has become 
an indeterminately long period of time.  
 
Figure 3 about here  
 
As the nineteenth century progressed, even before Darwin published 
On the Origin of Species (1859), these ideas were becoming less 
tenable. As a source of intellectual humility in scientific writing, this 
form of religious feeling was abandoned by most people, then largely 
forgotten. It has become necessary to find other counterweights to 
our pride in the achievements of modern medicine. 
 
Conclusions 
In his Essay, James Parkinson set out observations that lacked an 
overarching theory to hold all their components together. His cases 
presented a chronicle of physical decline from which he developed a 
generic clinical history that conferred a narrative structure on the 
course of the malady. The Essay came to function as a conduit 
through which older ideas about collecting and categorising clinical 
information made their way into medical practice, ideas which 
continue to complement modern neuroscience. Although Parkinson 
clearly believed he had identified something more than a loose 
collection of symptoms and signs—in his words, the ‘Shaking Palsy’ 
was ‘a species of disease’—our consideration of how the modern 
concept of PD has developed has not identified a single version of 
the condition. Today’s concept or ‘unit-idea’[30] of it is not an 
unchanging one; there is no clinically based definition of the 
condition continuous across two centuries that have elapsed since 
the Essay appeared. What has been inherited is an evolving hybrid 
concept informed by patient accounts, clinical methods and basic 
and applied science, reminiscent of R. E. Kendall’s analogy of how 
furniture finds a place in a modern household: 
‘… each generation has acquired a few new pieces of its own 
but has never [fully] disposed of those it inherited from its 
predecessors, so that amongst the inflatable plastic settees and 
glass coffee tables are still scattered a few old Tudor stools, 
Jacobean dressers and Regency commodes, and a great deal of 
Victoriana. A logician would have started by defining what he 
meant by disease as a whole and then produced individual 
diseases by sub-dividing the territory whose boundaries he had 
thus defined. Medicine … proceeded the other way and started 
with individual diseases.’[31] 
Although the tendency over the twentieth-century has been for 
symptoms and signs to play a subordinate role to measures and 
markers of cellular disruption and derangement in the diagnosis of 
most diseases, new medical conditions have continued to gain 
credence without meeting Parkinson’s ideal of an anatomy based 
diagnosis.  Aronowitz cites disease-syndromes such as Still’s disease, 
Reiter’s syndrome and Behcet’s syndrome as examples of clusters of 
symptoms, physical signs and biochemical and immunological 
markers, that have gained in both clinical and conceptual coherence 
since their original descriptions were first formulated.[32] 
Parkinson’s careful characterisation of a cluster of clinical features in 
a small number of patients has continued to advance medical 
understanding into the new millenium. Traces of the creative 
tensions which he faced when he wrote his Essay are still felt within 
neurology’s dimer of syndrome-disease. We have argued for a non-
doctrinal commitment to both sides of the interaction and for 
continuing intellectual and conceptual fluidity between them. Time 
will tell if a new construction of PD’s syndromic character which now 
embraces a defined prodromal phase and terminal dementia will 
supplant the one so memorably sketched in 1817 by James 
Parkinson. 
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CAPTIONS 
Figures 1 and 2 [please place side-by side in text]. 
Junction by St Leonard’s Church Shoreditch (both c.1800), showing 
the striking variety of postures and gaits visible at this busy 
intersection, only a stone’s throw from Parkinson’s childhood home 
and surgeon-apothecary’s practice in Hoxton Square. 
 
Figure 3 
Frontispiece to James Parkinson’s Organic Remains of a Former 
World (3 vol, 1804-11). With shells of antediluvian invertebrates in 
the foreground, Noah’s Ark rests on Mount Ararat. The rainbow 
reminds readers of God’s promise: ‘I do set my bow in the cloud, and 
it shall be for a token of a covenant between me and the earth’ 
(Genesis 9:13). 
 
 
